Anogeissus leiocarpus is a traditional medicinal plant, used to treat diarrhea, fever, coughs, rheumatism, leprosy, wounds and skin diseases and psoriasis. This study was aimed to investigate the antiangiogenic and cytotoxic effects of six extracts from Anogeissus leiocarpus (leaves and bark). Further, the tested biological activities were correlated with antioxidant capabilities, total phenolic and total flavonoid contents. In order to confirm the effect of the extract on motility of human endothelial cells, cell migration assay was conducted. In addition, VEGF suppressive effect of the extracts was assessed in endothelial cells. Finally, the antitumor effect of the leaves ethanolic extract was evaluated using in vivo human tumor xenograft model. A. leiocarpus extracts significantly inhibited the outgrowth of new vessels from rat aortic tissue explants by more than 50%. Hexane extract of the stem bark and ethanolic leaves extract profoundly inhibited the sprouting of microvessels (by 89.56% and 87.12% respectively) in rat aortic ring assay. The ethanol extract of the leaves inhibited HUVEC migration by 87.57 and 65.23% after 18 hours at 80µg/ml and 40µg/ml concentrations respectively; it also demonstrated significant inhibition of VEGF levels (45.32% and 30.52 % respectively) in treated endothelial cells. The ethanol extract of the leaves showed remarkable DPPH scavenging effect with IC 50 = 29.87µg/ml. Furthermore, it displayed higher levels of total phenolics and flavonoids compared to other extracts. Finally the ethanol extract of the leaves exhibited potent anti-tumorigenic effect in anthymic mice with ∆T/∆C =2.97 and 7.54% at doses 400 and 200mg/kg, respectively. These results may provide novel guidelines towards improved strategies using Anogeissus leiocarpus extracts based on the suppression of angiogenesis to curb tumors growth. The plant can be used as promising candidate for anti-neoplasic drug development.
Introduction
Cancer is a dreadful disease that a ects millions of people around the globe. Its complexity requires di erent strategies to reduce its morbidity and mortality that include cancer prevention, cancer therapy and impeding cancer recurrence. To achieve more success in treatment and chemoprevention, several approaches need to be applied targeting neoplastic cells and tumor microenvironment. and uterus functions (Carmeliet, 2005; Folkman & Klagsbrun, 1987) . Nevertheless, pathologic angiogenesis is involved in some diseases such as cancer, diabetic retinopathy; chronic in ammation, atherosclerosis and psoriasis (Kim, West, & Byzova, 2013; Kumamoto, Nakashima, & Sueishi, 1995) . Cancers that lack angiogenesis remain dormant while aggressive growth follows the acquisition of a blood supply, so tumor angiogenesis is a key event that supply tumor with nutrients and enhance cancer metastases (Sagar, Yance, & Wong, 2006) . Anti-angiogenic approach to prevent and treat cancer represents a priority area in investigative tumor biology.
In the treatment of some types of cancer, botanicals have long been used traditionally and o en less associated with the side e ects of modern chemotherapy. Medicinal herbs have increasingly become important as therapeutic agents and a source of chemical diversity in drug discovery (Subbaraju & Trimurtulu, 2004) .
Anogeissus leiocarpus has a large ecological distribution, ranging from the borders of the Savanna up to the humid tropical forests region (Hennenberg et.al ; Porembski, 2005) . It is used traditionally for the treatment of helminthiasis, trypanosomiasis, malaria and dysenteric syndrome. Also it used for the treatment of diarrhea, fever, coughs, rheumatism, leprosy, wounds and skin diseases and psoriasis (Okpekon et al., 2004; Singh et al., 2016) .
Furthermore Anogeissus leiocarpus has also been shown to have antimicrobial activities, potent in vitro antioxidant and organ protective properties in vivo (Konaté et al., 2011; Ottu, Atawodi, & Onyike, 2013) . Phytochemical studies have shown that A. leocarpus leaves are rich in alkaloids, avonoids and phenolic, and saponins compounds ( eresa Ibibia, Oghenerobor Benjamin, & Stephen Olugbemiga, 2016) , the presences of these biochemical components suggest their potential use in cancer treatment.
Free radicals and oxidative agents implicated in the pathogenesis of diseases such as cancer, diabetes, hypertension, cardiac disorder, arteriosclerosis ect. Free radicals are capable of oxidatively damaging lipids and proteins as well as DNA integrity (Phaniendra, Jestadi, & Periyasamy, 2015; erond, 2006) . Natural products containing polyphenols have been widely studied and used as a source of antioxidants to scavenge excessive free radicals in various disease models (Russell & Duthie, 2011; Shahidi & Naczk, 1995) . Antioxidants have been reported to have potent antiangiogenic properties, these compounds work by regulating angiogenesis modulators such as vascular endothelial growth factor (VEGF) (Papiewska-Pająk, et al; Boncela, 2017) or by changing the redox microenvironment of tumor vasculature (Saggar, Yu, Tan, & Tannock, 2013) , thus potentially can modulate the process of angiogenesis. Antiangiogenic activity evaluation of the extracts may reveal antitumor and chempoprevention potential of the plant due to its inhibitory e ect of blood vessel formation (Hassan et al., 2016) . Given its known antioxidant value, this study explores for the rst time the potential antiangiogenic and antitumor properties of extracts from Anogeissus leiocarpus. MAPRI-380774/2016) was deposited at the herbarium of the institute.
Materials and Methods

Plant
Preparation of extracts
Collected plant materials were oven dried at 45ºC. e plant material was successively extracted with n-hexane, ethanol and water. N-hexane extract was prepared by adding 300 ml n-hexane to 50g of the pulverized plant material, extraction was carried out at 40ºC with intermittent shaking. e extract was ltered and concentrated at 45ºC under vacuum by rotary evaporator (Buchi, USA) and further dried overnight at 45ºC. e plant residues were then re-extracted with ethanol and water each for further 24 h and were processed as mentioned above. Stock solutions of the extract were prepared at 10mg/ml in 100% dimethyl sulfoxide (DMSO).
e stock solutions as well as DMSO (vehicle) were diluted with cell culture medium, so the highest DMSO concentration exposed to the cells and explanted tissue was 0.1 % v/v. Rat aorta ring assay e assay was performed according to standard protocol with minor modi cations (Brown et al. 1996; Blacher, et al., 2011; Hassan et al., 2014) .
Preparation of aortic rings. e animals were humanely sacri ced via cervical dislocation under anesthesia with CO 2 in close chamber. A midline was made into the abdominal and thoracic cavities including splitting of the sternum. oracic aortas were excised, rinsed with serum free media, broadipose tissue removed and were cross sectioned into thin rings of about 1mm thickness.
Preparation of the tissue culture plates. Medium for the lower layer was prepared by adding brinogen and aprotonin at 3 mg/ml and 5mg/ml, respectively to M199 basal medium. e 300µl of this mixture was loaded in each well of 48-well plate.
Aortic ring sections are then place in each well. 10µl of thrombin; prepared at 50 NIH U mL -1 in 0.5 M NaCl; bovine serum albumin; was added to each well and was allowed to solidify at 37°C in 5% CO 2 for 60-90 min. e top layer medium was prepared by adding the following to M199 basal medium: FBS at 20% v/v, L-glutamine at 1% aminocaproic acid at 0.1% amphotericin B at 1% and gentamicin at 0.6%. e extracts were added to top layer medium at 100µg/ml and were incubated at 37ºC in 5% CO 2 in a humidi ed incubator. On day four the top layer medium was changed with fresh medium prepared as previously mentioned with the plant extracts added at 100µg/ml. DMSO was used as a negative control.
Quantification of the blood vessels outgrowth. e magnitude of blood vessels outgrowth was quanti ed according to the technique developed by Nicosia et al. (1997) (Staton et al., 2004) .
Brie y, the distance of blood vessels outgrowing from the primary tissue ex-plant was measured on day ve under the 4x magnication power of inverted light microscope supplied with Lecia Quin computerized imaging system. e growth distance of at least twenty blood vessels per ring was measured; blood vessels were selected at regular intervals around the rings to reduce the bias. e experiment was performed in triplicates each replicate containing six rings and the results were presented as a mean percent inhibition to the negative control (n=±5) Standard Deviation (SD).
Cytotoxicity assay e MTT cytotoxicity assay was performed according to the method developed by Mosmann (1983) with minor modi cations Mosmann, 1983 
Determination of total phenols
Total phenols in tested extracts were determined by a colorimet- A erwards absorbance was measured at 725nm. Gallic acid was used (5-80 µg) to construct the standard calibration curve. e results were expressed as gallic acid equivalents per 100 mg of extract (mg GAE/100mg).
Determination of total Flavonoids
e total avonoid contents in studied extracts were determined using aluminum chloride colorimetric method with quercetin as standard (Mammen & Daniel, 2012) . A solution of 6 mg/ml of A. leiocarpus extracts in 80% methanol and di erent concentrations of quercetin (0.007, 0.015, 0.0313, 0.0625, 0.125, 0.25, 0.5, and 1 mg/ml in 80% methanol) were prepared.
Brie y, 500 µl of plant extracts and each concentration of quercetin (Sigma Aldrich, Germany) were pippetted in respective test tubes followed by 0.1 ml of 10% (w/v) aluminum chloride (R & M Chemicals, UK), 0.1 ml of 1 M potassium acetate (Merck, Germany), 1.5 ml of methanol and 2.8 ml of distilled water. e test tubes were thoroughly mixed and a er incubating at room temperature (24 to 26°C) for 30 min, the absorbance of the reaction mixture was measured at 415 nm with Microplate Reader So ware (TECAN Group Ltd., Switzerland) against blank. e amount of 10% (w/v) aluminum chloride was substituted by the same amount of distilled water in a blank. e concentration of total avonoid contents of the extracts were determined using a standard curve with quercetin (Sigma-Aldrich Chemie, Steinheim, Germany) (0 to 50mg/ml) as the standard. e data were presented as mean (n = 3). Standard Deviation (SD)
DPPH scavenging effect
DPPH scavenging e ect of extracts was investigated as described by Sharma and Bhat (2009) (Sharma & Bhat, 2009 ). Brie y, stock solution of DPPH was prepared in methanol at 200 µM, and serial dilution of extracts was prepared in methanol to obtain (200, 100, 50, 25 and 12.5µg/ml). DPPH reagent was added at nal concentration of 50 µM and incubated at 30°C in the dark for 30 min.
Consequently, absorbance was measured at 517 nm and DPPH scavenging activity was calculated using the formula (1-(absorbance of samples-blank)/ (absorbance of negative controlblank)) × 100%. Median inhibitory concentration (IC 50 s) were calculated from the dose response curves (n = 3). Gallic acid was used as a positive control and the solvent (methanol) was used as a negative control.
Migration Assay e assay was carried out as described previously (Hassan et al., 2017; Liang, Park, & Guan, 2007) . In brief, HUVECs were seeded in 6 well plates till the formation of a con uent monolayer a er which a wound was created using 200μl micropipette tip. e In vivo antitumor study HCT-116 human colorectal carcinoma cells was selected as a model of colon cancer (Baghel, Shrivastava, RS Baghel, & Rajput, 2012 ). e cells were propagated in RPMI 1640 medium with 10%
FBS and 1% PS solution. 80% con uent HCT-116 cells cultures in T75 asks were trypsinized and re-suspended in 10 ml fresh medium, the cells were collected by centrifugation at 1000 rpm for 5 minutes and washed with a sterile PBS. e nude mice with aged 5 -7 weeks were injected subcutaneously in the right ank with 5 × 106 cells in 200 µl culture medium using 1 ml insulin syringe (27 G needle).
A er one week of tumor initiation, animals were divided randomly into four groups of 6 animals each. Group 1 received 0. were measured by a caliber in 2 angles, length and width as well as depth (Tomayko & Reynolds, 1989 ). e tumor size was calculated by applying the formula: Tumor volume (mm2) = (W + L) / 2) ^ 3) × 2 Where W is the width and L is the length. Also following value was calculated :% ∆T/∆C, where, ∆T = T − ∆0 and ∆C = C − ∆0
(∆0 is the average tumor volume at the beginning of the treatment, T and C are the tumor volumes at a specified day for treated and control groups, respectively). Generally, the ∆T/∆C value in percent is used as an indication of antitumor e ectiveness, and a value of ∆T/∆C ≤42% is considered as signi cant antitumor activity by the Division of Cancer Treatment, NCI, NIH (Corbett et al., 2004) .
Haematoxylin and Eosin (H&E) histology staining e excised tumors were cut into sections of about 0.5cm 2 sizes and xed in 10% formalin for 48 h, embedded in para n wax (Leica EG1160, Germany) and the blocks trimmed and sectioned to about 5×5×4μm size using a microtome (Leica RM2155). e tissue sections were mounted on glass slides using a hot plate (Leica HI1220, Germany) and subsequently treated with alcohol.
e processed tissues were rinsed with tap water and nally stained with the Harris's haematoxylin and eosin (H & E) (Luna & Armed Forces Institute of, 1968) and examined under an inverted light microscope (EVOS) at 4x magni cation.
Results
In this study we screened six extracts obtained from the leaves and stem bark of Anogeissus leiocarpus using three solvents (n-hexane, ethanol and water). Sequencing extraction of leaves and bark of Anogeissus leiocarpus reveals that all leaves extracts exhibited higher yield compared with stem bark extracts. e extract of the leaves proofed to have the superior yield 12.39%
(w/w) followed by water extract of the same organ 11.85% (w/w) and water extract of the bark 6.81% (w/w). e hexane extract of the bark showed the lowest yield 0.195 % (w/w) with more than 50% inhibition of the blood vessels outgrowth were considered signi cant, so all the extracts of Anogeissus leiocarpus showed signi cant antiangiogenic activity except the n-hexane extract of leaves (29.10%). Table 2 .
In this ex-vivo rat aorta ring assay, among six extracts screened, ethanol extract of the leaves and hexane extract of bark profoundly inhibited the sprouting of new blood vessels from explanted tissue, therefore it was subjected for further mechanistic studies on HUVEC human endothelial cells and evaluated for antitumor e cacy due to its ability to inhibit the growth of new blood vessels and to its safety pro le.
Cytotoxicity
In vitro cytotoxicity test on human normal and cancer-derived cells is essential for determining the real antiangiogenic e ect from inhibition of vasculature due to toxicity e ect thus was also done in the current study.
e MTT assay was used to screen cytotoxic activity of six extracts of Anogeissus leiocarpus. Two cancer cell lines were used for general screening namely colon cancer cell line (HCT-116) and breast cancer cell line (MCF-7). Two normal cell lines (HUVECs and CCD-18 Co) were also tested on for comparison. e cells were treated with extracts at 100 µg/ml for 48h, the assay was performed in quadricates and the results were presented as a mean percent inhibition to the negative control ±SD. Table 3 shows the cytotoxicity result by MTT assay. e n-hexane of the bark found to be selectively cytotoxic against HUVEC cell line with inhibitory e ect 76.87% it was also moderately cytotoxic against HCT-116 colon cancer cell line, as well as ethanol extract of the same organ with inhibition 61.24% and 58.25% respectively. e rest of the extracts were non-toxic on all tested cell lines.
Antioxidant activity
In the current study, antioxidant assays were carried out on six extracts to correlate the antiangiogenic e ect and antioxidant activity of each extract. ree methods were used to assess the antioxidant activity of di erent extracts that is DPPH radical scavenging activity, total phenolic and total avonoid contents.
Ethanol extract of the leaves and the bark exhibited very high free radical scavenging e ect with IC 50 =29.87 µg/ml and 43.34 µg/ml respectively in DPPH scavenging assay. Hexane extract of the leaves showed the lowest antioxidant e ect (with IC 50 =193.05 µg/ml) followed by the water extract of the bark (111.43 µg/ml). In this study, extracts with high DPPH radical scavenging activity, total phenolic and total avonoid content i.e. ethanol and water extracts, showed high level of antiangiogenic activity.
N-Hexane extract of the leaves having the lowest total phenolic and avonoid level exhibited the lowest antiangiogenic activity.
Results obtained from this study clearly showed that there is a good accordance with antioxidant activity and antiangiogenic e ect of extracts, since the polyphenols and avonoids inhibit the initiation and progression of angiogenesis (Walter et al., 2009 ).
erefore, botanical may play an important role in halting angiogenesis and tumor progression.
Effect of Anogeissus leiocarpus extracts on VEGF expression. To investigate the mechanism of action for antiangiogenic property of A. leocarpus, we studied the e ect of active extracts on expression of VEGF165 on HUVECs. It signi cantly reduced the level of VEGF compared to untreated cells (P< 0.01). At concentration 50 and 100μg/ml ethanol extract inhibited the VEGF by 30.32 % and 44.05 % respectively, the VEGF concentration in HUVEC cell lysate treated with ethanol extract of the leaves at 50μg/ml was 0.990pg/ml and at 100μg/ml was 0.86pg, while it was 1.953 pg/ml in untreated cells (Figure 2A ). Water extracts of leaves and stem bark also signi cantly inhibited VEGF expression at high concentration by 40.15% and 39.69% respectively ( Figure 2B ). e results achieved in this study suggests that
A. leiocarpus leaves ethanol extract (LEE) inhibited angiogenesis by curtailing secretion of the main angiogenesis growth factor (VEGF)
Cell migration assay e e ect of ethanol extract on HUVECs cell migration was assessed using wound healing assay ( gure3A). It substantially reduced endothelial cell (HUVECs) motility, at concentration 40μ g/ml the extract inhibited migration of cell by 51.7 ± 2.11 % and 65.23±2.6 % a er 12 and 18 h incubation period, respectively (P < 0.05). At 80μg/ml it inhibited HUVECs migration by 74.6 ± 1.37% and 87.1± 2.7 % a er 12h and 18h treatment, respectively (P < 0.001) ( Figure 3B ).
VEGF is the most important mitogenic and survival factor for vascular endothelial cells; many chemopreventive agents have been shown to inhibit VEGF mediated signaling and biological e ects in endothelial cells (Albrecht et al., 2010; Rini & Small, 2005) . As discussed earlier the ethanol extract of the leaves profoundly inhibited the expression of VEGF in HUVECs endothelial cells suggesting that it inhibits cell endothelial cell migration via inhibition of VEGF expression. 
Antitumor activity of Anogeissus leiocarpus leaves extract
Discussion
Botanical extracts and their isolated phytochemical constituents are potential leads for developing antiangiogenic therapeutics due to their high antioxidant property beside phytochemical manifest it anti-angiogenic e ect through multiple interdependent processes including singling process, gene expression and enzyme activities . e current study aimed to evaluate the antiangiogenic and antioxidant activities of
Anogeissus leiocarpus as well as to assess its antitumor properties.
Six extracts obtained from the leaves and stem bark using three solvents, n-hexane was used to obtain the hydrophobic constituents whereas the intermediate hydrophobic and hydrophilic gained by ethanol and most hydrophilic obtained by water.
Tumors do not grow progressively beyond 2 mm 3 in size and shed metastasis unless they acquire the capacity to induce blood supply from the surrounding stroma. Angiogenesis is a formation of new blood vessels from the pre-existing vasculature. Since angiogenesis initiation is crucial for cancer growth and metastasis, the anti-angiogenic therapy seems to be an important coadjuvant treatment against solid tumors. Moreover, a er surgical resection of the malignancy, angiogenesis inhibition can help in avoiding cancer reappearance (Quail & Joyce, 2013 ).
e angiogenesis signaling pathways form a complex, interconnected web. Inhibition of one pathway may result in compensation Carmeliet & Jain, 2011; De Palma, Biziato, & Petrova, 2017) . In this study we aimed to evaluate the antioxidant activity of di erent extracts and to correlate it with antiangiogenic e ects. ree methods were used to attain antioxidant activity (DPPH free radical scavenging, total phenolic and total avonoids contents). e results showed that ethanol extract of the leaves and bark scored potent antioxidant activity with high phenolic and avonoids consents. Noteworthily, extracts with high antioxidant activity exhibited signi cant antiangiogenic activity.
Several studies demonstrated that numerous antioxidants found in natural products (catechins from teas, resveratrol, polyphenols, avonoids, iso avones, lycopene, pigment epithelium derived factor, glutathione); nutritional components (vitamins C, D, E, β-carotene and selenium); piruvate, pyrrolidine dithiocarbamate, and organoselenium compounds) were able to inhibit angiogenesis (Jiang, Agarwal, & Lü, 2000; Samoylenko et al., 2013) . Obviously, antioxidants have potential to interfere and downregulate tumor vasculature.
It has been indicated that regular consumption of polyphenols such as green tea and red wine associated with less occurrence of cancer and coronary heart disease (Vauzour et al, 2010) . Previous studies demonstrated that polyphenolic compounds profoundly inhibit VEGF expression and H 2 O 2 -induced release of VEGF in vascular smooth muscle cells a er administration of red wine (Oak, El Bedoui, & Schini-Kerth, 2005) . Also polyphenols exhibited ability to scavenge ROS such hydroxyl radical and superoxide anion (Upadhyay & Dixit, 2015) and inevitably it curb the angiogenesis since ROS initiate neovascularization via induction of stimulatory angiogenic growth factors such as vascular endothelial growth factor (VEGF), angiopoetin-1 and 2, interleukin-8
(IL-8), broblast growth factor basic (bFGF), platelet-derived growth factor (PDGF) and angiotensin II (Murakami & Simons, 2008; Veltmann et al., 2016) . Epigallocatechin gallate (EGCG) a major polyphenol in green tea inhibited VEGF expression in many types of cancer cells by inhibiting epidermal growth factor receptor (EGF-R) (Chen et al., 2011) .
Resveratrol is a polyphenolic compound found in grapes, juice grapes, red wine and other fruits. It has been reported to inhibit (Gupta & Qin, 2003) .
VEGF plays a fundamental role in the neo-vascularization and vascular permeability. It's well known angiogenesis mediator in cancer and it's the main angiogenesis growth factor that initiate di erent steps in the angiogenesis cascade, such as endothelial proliferation, migration and di erentiation (Gupta & Qin, 2003) .
us, it is obvious that disruption of VEGF-signaling will result in the inhibition of angiogenesis process and pro-survival e ects 
